Actionable news
0
All posts from Actionable news
Actionable news in ZFGN: ZAFGEN Inc,

UPDATE 3-FDA puts Zafgen's obesity drug trials on partial hold

* Zafgen confirms that patient who died had received its drug

* Partial hold affects all ongoing and planned trials on drug

* To report results from late-stage study in Q1 2016

* Shares fall as much as 33 pct premarket (Adds details)

Oct 16 (Reuters) - Zafgen Inc said the U.S. Food and Drug Administration has put a partial hold on the development of its obesity drug, two days after the drug developer reported the death of a patient during a late-stage study.

The company's stock was down about 25 percent at $15.75 in premarket trading.

Zafgen confirmed that the...


More